


| Key | % Net Assets |
|---|---|
| 7.9% | |
| 7.1% | |
| 6.2% | |
| 5.8% | |
| 73% |
| Name | % Net Assets |
|---|---|
| AstraZeneca | 7.9% |
| GlaxoSmithKline | 7.1% |
| Lloyds TSB | 6.2% |
| Vodafone | 5.8% |
| Royal Dutch Shell 'B' | 5.5% |
| Morrison (W) Supermarkets | 4.3% |
| HBOS | 4.3% |
| Smith (DS) | 3.6% |
| Aviva | 3.5% |
| Carnival | 3.5% |
No asset data available.
| Date | n/a |
|---|---|
| Bid | 0.00 |
| Offer | 0.00 |
| Currency | n/a |
| Change | 0.00 |
| % | n/a |
| YTD change | 0.00 |
| YTD % | n/a |
| Fund Inception | 12/09/2002 |
|---|---|
| Fund Manager | Ian Carstairs |
| TER | - |
| Minimum Investment | |
|---|---|
| Initial | 500 |
| Additional | 100 |
| Savings | 20 |
| Charges | |
|---|---|
| Initial | 5.00% |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.01 |
| Sharpe ratio | 0.18 |
You are here: research